Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...

StableView Tech Podcast with Colin Fisher and Gary Yeoman

In this informative and entertaining podcast, StableView Asset Management President and Portfolio Manager Colin Fisher talks with Chairman and CEO of iLOOKABOUT , Gary Yeoman, about a wide variety topics of in the emerging technology-based real estate sector. iLOOKAB...

Live from the Floor of VRIC 2020 with Mickey Fulp

Stockhouse Media’s Cindy Broad was joined live at VRIC 2020 by Mickey Fulp: The Mercenary Geologist . Mickey is a Certified Professional Geologist with a B.Sc. Earth Sciences with honor from the University of Tulsa, and M.Sc. Geology from the Universi...

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. On Wednesday morning, T2 BioSystems Inc. (TTOO:NASDAQ) announced receipt of funding from the U.S. Department of Health a...

PhaseBio Shares Are on a Tear After Reporting Phase 2a Trial Results

The clinical-stage biopharmaceutical stock surged more than 30% Wednesday following a report that PB2452 caused immediate and sustained reversal of ticagrelor in older and elderly subjects. In a press release issued September 24, PhaseBio Pharmaceuticals Inc. (PHAS...

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...

June 18th 2020, Silver Chartbook – Make it your own

Make it your own Trading is often compared to professional sports. This not only due to the competitive element. To produce outstanding performance different methodologies are required to reach elevated performance levels. Successful market participation is not achiev...

The Company That’s Redefining the Staffing Industry

Get to know capital market moguls, mavens and management teams in a more relaxed setting. PROFIT! episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases f...

Fear Drives Market Expectations

The continued upside price move in Gold is a very clear sign that fear is starting to enter the global markets again. We read an article last night that suggested many professional fund managers are preparing for a bigger downside price move as well as expecting the US Fed to ...

Critical Cesium Supply Is Sold to China

A Monday Morning Musing from Mickey the Mercenary Geologist Contact@MercenaryGeologist.com July 1, 2019 Little more than two months ago, I reported on the pending sale of America’s world monopoly in cesium, a Trump Administration-designated critical...
1 2 3 4 5 6 7 8 9 10 ...